ArticleJournal of translational medicine2026
A 3-tier information fusioned framework featuring explainable deep active optimized CRNet for accurate heart disease prediction.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHeart disease remains a leading cause of global morbidity and mortality, emphasizing the need for early and accurate prediction. Traditional models, however, often struggle with high class imbalance, limited accuracy, inadequate hyperparameter tuning, reliance on sparsely labeled data, and poor interpretability.
methodsTo address these limitations, we introduce a novel 3-tier information fusioned framework integrating Oversampling Using the Propensity Score (OUPS), ConvRecurrentNet (CRNet), an optimized CRNet, and CRNet enhanced with Uncertainty-Based Sampling (UBS). Initially, the highly imbalanced heart disease health indicator dataset is balanced using OUPS while preserving the underlying data distribution. In the first tier, we develop a new deep model; CRNet which combines gated units to capture temporal dependencies and convolutional layers for efficient spatial feature extraction. The second tier leverages the grasshopper optimization algorithm to optimize CRNet configuration and classification performance through hyperparameter tuning. At the third tier, we use an active learning based UBS to address the problem of sparse labeled data selecting the most informative samples for effective CRNet model learning. Model performance and generalizability are assessed through 10-fold cross validation and one-way analysis of variance. Interpretability is ensured using explainable artificial intelligence (AI) methods, local interpretable model-agnostic explanations and shapley additive explanations.
resultsImprovements are observed across all performance metrics: 3.45%, 5.75%, and 8.05% in accuracy, 3.45%, 6.90%, and 12.64% in precision, 4.65%, 5.81%, and 4.65% in recall, 4.65%, 6.98%, and 15.12% in F1-score, 1.04%, 2.08%, and 3.13% in receiver operating characteristic-area under the curve, 8.00%, 9.33%, and 17.33% in Matthews correlation coefficient, 12.16%, 13.51%, and 18.92% in Cohen’s Kappa, and log loss reduction of 23.64%, 29.45%, and 45.82% across CRNet, optimized CRNet, and CRNet with UBS, respectively.
conclusionThe proposed 3-tier fusion framework enhances heart disease prediction by balancing data, optimizing parameters, and applying active learning to address labeled data scarcity. Explainable AI further improves transparency and supports real-world clinical adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.